The strategic alliance between Roche and reMYND is nominated for a Scrip Award

In the press

The strategic Alliance between Roche and reMYND to develop novel therapeutics that could slow down neurodegeneration in Parkinson’s and Alzheimer’s patients is nominated for the Scrip Award “Best Partnership Alliance”. The winners will be announced in London on November 3rd, 2011. The Scrip Awards celebrate each year Excellence in the Pharmaceutical Industry.

More info on this nomination in Dutch only

Update Nov 2011: reMYND wants to congratulate AstraZeneca, Agendia and The Netherlands Cancer Institute for their  Colorectal Cancer Collaboration, winning the Scrip Award in the category  “Best Partnership Alliance”

Visit the Scrip Award website